Rebecca L Ashare, Ph.D.
Rebecca L Ashare, Ph.D.
Research Assistant Professor of Psychiatry
Department: Psychiatry
Contact information
Center for Interdisciplinary Research on Nicotine Addiction
3535 Market St, Suite 4100
Philadelphia, PA 19104
3535 Market St, Suite 4100
Philadelphia, PA 19104
Office: (215) 746-5789
Email:
rlashare@mail.med.upenn.edu
rlashare@mail.med.upenn.edu
Links
Center for Interdisciplinary Research on Nicotine Addiction website
Search PubMed for articles
Center for Interdisciplinary Research on Nicotine Addiction website
Search PubMed for articles
Education:
B.A (Psychology)
State University of New York at Buffalo, 2003.
M.A (Clinical Psychology)
State University of New York at Buffalo, 2007.
Ph.D. (Clinical Psychology)
State University of New York at Buffalo, 2011.
Permanent linkB.A (Psychology)
State University of New York at Buffalo, 2003.
M.A (Clinical Psychology)
State University of New York at Buffalo, 2007.
Ph.D. (Clinical Psychology)
State University of New York at Buffalo, 2011.
Description of Research Expertise
My research focuses on evaluating more effective treatments for nicotine dependence, with a specific focus on pharmacotherapies that reduce nicotine withdrawal-related cognitive deficits. Through the use of human laboratory studies my work has emphasized psychophysiological, cognitive, and stress responses related to smoking behavior. Since joining the Center for Interdisciplinary Research on Nicotine Addiction (CIRNA), we have begun research on the potential therapeutic benefits of pro-cognitive medications for nicotine dependence. Current projects are aimed at understanding how genetic factors, pre-treatment cognitive function, and neural substrates affect treatment response.Selected Publications
Ashare, RL, Falcone, M, and Lerman, C: Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology in press.Ashare R L, Karlawish J H, Wileyto E P, Pinto A, Lerman C: APOE ɛ4, an Alzheimer's disease susceptibility allele, and smoking cessation. The pharmacogenomics journal Dec 2012.
Strasser Andrew A, Ashare Rebecca L, Kaufman Madeline, Tang Kathy Z, Mesaros Clementina, Blair Ian A: The effect of menthol on cigarette smoking behaviors, biomarkers and subjective responses. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 22(3): 382-389, Mar 2013.
Ashare Rebecca L, Tang Kathy Z, Mesaros A Clementina, Blair Ian A, Leone Frank T, Strasser Andrew A: Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers. Journal of psychopharmacology (Oxford, England) 26(10): 1383-1390, Oct 2012.
Rhodes Jessica D, Hawk Larry W, Ashare Rebecca L, Schlienz Nicolas J, Mahoney Martin C: The effects of varenicline on attention and inhibitory control among treatment-seeking smokers. Psychopharmacology 223(2): 131-8, Sep 2012.
Ashare Rebecca L, Ray Riju, Lerman Caryn, Strasser Andrew A: Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: A pilot feasibility study. Drug and alcohol dependence May 2012.
Ashare Rebecca L, Sinha Rajita, Lampert Rachel, Weinberger Andrea H, Anderson George M, Lavery Meaghan E, Yanagisawa Katherine, McKee Sherry A: Blunted vagal reactivity predicts stress-precipitated tobacco smoking. Psychopharmacology 220(2): 259-68, Mar 2012.
Hawk L W, Ashare R L, Lohnes S F, Schlienz N J, Rhodes J D, Tiffany S T, Gass J C, Cummings K M, Mahoney M C: The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial. Clinical pharmacology and therapeutics 91(2): 172-80, Feb 2012.
Ashare Rebecca L, McKee Sherry A: Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers. Experimental and clinical psychopharmacology 20(1): 63-70, Feb 2012.
Ashare Rebecca L, Hawk Larry W: Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms. Psychopharmacology 219(2): 537-47, Jan 2012.